tiprankstipranks
Trending News
More News >
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Similar Stocks

Compare
2,308 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ACADIA Pharmaceuticals
$17.44
$2.43B
10.69
14.36%
11 Buy
5 Hold
0 Sell
Moderate Buy
ImmunityBio
$2.07
$1.77B
-74.51%
2 Buy
1 Hold
0 Sell
Moderate Buy
Merus
$40.90
$2.96B
-9.35%
15 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$17.30
$2.40B
-59.31%
13 Buy
8 Hold
0 Sell
Moderate Buy
Immunovant
$14.02
$2.38B
-52.79%
8 Buy
2 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$38.47
$2.55B
-5.99%
12 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACAD
ACADIA Pharmaceuticals
17.44
2.26
14.89%
IBRX
ImmunityBio
2.07
-6.56
-76.01%
MRUS
Merus
40.90
-4.95
-10.80%
APLS
Apellis Pharmaceuticals
17.30
-25.71
-59.78%
IMVT
Immunovant
14.02
-15.86
-53.08%
MLTX
MoonLake Immunotherapeutics
38.47
-3.24
-7.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis